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Key findings
 Most studies using routinely collected health data
(RCD) are insufficiently reported. For example, it is
frequently impossible to know which exposure or
intervention is associated with which outcome in
which population orminimal prerequisites for replica-
tion/assessment of scientific validity are often lacking.
What this adds to what was known?
 Even years after introducing reporting guidelines
for observational studies, many studies from
various clinical and epidemiologic areas are poorly
reported.
What is the implication and what should change
now?
 Specific reporting guidelines for studies using
RCD are necessary to address specific characteris-
tics of such research.
 Authors, peer reviewers, and editors need training
to apply both novel and established reporting
guidelines to ensure better and more complete
research reporting.1. Introduction
Routinely collected health data (RCD) are defined as
data collected for purposes other than research [1,2]. Exam-
ples include health administrative data, electronic health re-
cords, and disease or clinical registries. Increased ability to
store, process, and quickly access large amounts of such
data led to increasing collection and usage for health
research. Using such novel data sources involves unique
challenges for research reporting, for example, the descrip-
tion of database characteristics or record linkage methodol-
ogy [3]. Poor reporting wastes efforts and resources [4].
Guidelines such as the STrengthening the Reporting of
OBservational studies in Epidemiology (STROBE) state-
ment have been developed and endorsed by many journals
to improve reporting of biomedical research [5]. Inadequate
or incomplete reporting has been shown in observational
studies on general medical interventions that were pub-
lished before introduction of STROBE [6] and in more
recent evaluations that addressed specific research areas,
including cancer [7], hand surgery [8], dermatology [9],
plastic surgery [10], or magnetic resonance imaging [11].
We analyzed the reporting of any type of observational
study using RCD in a randomly selected sample of studies
published in 2012 which were identified in PubMed. Wefocused on reporting domains that are central with regard to
the study’s design, its research question, and basic prerequi-
sites for study results replication. We selected items address-
ing these reporting domains in STROBE, and we developed
a set of new items deemed specifically important for reporting
of research using RCD. This new set included items that
directly correspond to the selected STROBE items and items
that focus on selected specific characteristics ofRCDresearch.
Using a sample of recent publications, we systematically
evaluated these reporting items. In ancillary analyses, we
explored if reporting affects both low- and high-impact jour-
nals and if better reporting is associated with more citations.
We aimed to assess the present state of reporting and provide
a first empirical estimate of its quality to inform the develop-
ment of a specific reporting guideline for RCD studies by the
REporting of studiesConducted usingObservational Routinely
collected health Data (RECORD) working committee [12].
RECORD has recently been published as an extension of the
STROBE guidelines and aims to enhance transparency of
research reporting and provide guidance to adequately report
methods and findings of research using RCD [13].2. Methods
2.1. Eligibility of studies
We selected a sample of English language studies that used
RCD and reported outcomes related to the health status of per-
sons or a population, such as mortality or morbidity. For
example, we included publications detailing epidemiologic
research on incidence and prevalence of diseases or risk factors
or comparative effectiveness research studies measuring treat-
ment effects. We did not consider studies on outcomes such
as costs or care processes. We included nonexperimental
studies in humans based on any type of health data that were
routinely collected, that is, for purposes other than research.
We also included analyses based on registries, albeit registries
characteristically comprise at least one actively collected data
element [14]. Therewere no restrictions with respect to charac-
teristics of study participants.
2.2. Literature search
We searched PubMed for studies published in 2012 (search
date June 6, 2013) using terms related to RCD, including con-
structs for ‘‘database,’’ ‘‘registries,’’ ‘‘electronic health re-
cords,’’ and ‘‘administrative data/routine data’’ (Webappendix
1 at www.jclinepi.com). We integrated the search strategy for
electronic health records provided by the National Library of
Medicine into our strategy [15]. An information specialist
formally peer reviewed the strategy [16].
2.3. Study selection
The 24,929 hits in PubMed were exported to Microsoft
Excel (Microsoft Corporation, Redmond, WA, USA) and
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(L.G.H. and one of E.I.B., S.M.L., E.v.E.) screened titles
and abstracts in this order and excluded studies obviously
not meeting eligibility criteria. Any disagreements were
resolved by discussion. We obtained full texts of the first
150 potentially eligible references. The sample size was
determined arbitrarily based on our experience with similar
projects [9]. We determined eligibility of full texts in teams
of independent reviewers (two of L.G.H., E.I.B., S.M.L.,
M.B., B.K., J-.M.J., E.H., E.v.E.). Any disagreements were
resolved by consensus among the larger group.2.4. Extraction of study characteristics
For each eligible RCD study, we extracted the study
characteristics including RCD type, area of research (epide-
miology, e.g., risk factors of diseases; clinical/medical, e.g.,
comparative effectiveness of medical treatments), type of
disease/condition of participants, and characteristics of re-
ported analyses. We classified types of RCD as shown in
Webappendix 2 at www.jclinepi.com. Data were extracted
by teams of two reviewers (two of L.G.H., E.I.B., S.M.L.,
M.B., B.K., J-.M.J., E.H., E.v.E.). Any disagreements were
resolved by consensus among the two reviewers or with a
third reviewer (L.G.H.).
One reviewer recorded if journals endorsed the
STROBE statement according to information on the
STROBE website (L.G.H.) [17].
To compare the citation impact metrics of adequately
and inadequately reported studies (per reporting item),
bibliographic information was extracted from ISI Web of
Knowledge, that is, the 2012 impact factor (IF) of the pub-
lishing journal and the number of citations (all databases)
up to February 2015 that a study has received. This was ex-
tracted by one researcher and verified by another.2.5. Evaluation of reporting quality
2.5.1. Selection and development of reporting items
We evaluated five selected reporting items based on the
STROBE checklist [5] (S1eS5) and eight newly developed
items (R1eR8) for RCD research (Table 1; the prefix ‘‘S’’
denotes items based on STROBE; the prefix ‘‘R’’ denotes
newly developed items deemed important specifically for
RCD studies. Further details and examples of reporting
are shown in Webappendix 3 at www.jclinepi.com)
We aimed to reflect the reporting of the study design and
research question, study replication, and RCD specifics. Se-
lection of STROBE items and development of new RCD
items was based on expert opinion of the authors
(L.G.H., E.I.B., S.M.L., E.v.E.) without a formalized devel-
opment process.
We operationalized all items into dedicated questions
that can be clearly answered with ‘‘yes,’’ ‘‘partly,’’ or
‘‘no,’’ indicating adequate (‘‘yes’’) or inadequate (‘‘no’’) re-
porting. We used the ‘‘partly’’ answer when not all aspectswere adequately reported, for example, when several eligi-
bility criteria existed, but some were described and others
were not. We accepted references to other publications as
adequate descriptions.
We tested the item operationalization and developed
rules and detailed extraction instructions in a small pilot
study using a selected sample of three articles that were ex-
tracted and assessed by the larger group of the authors. We
then assessed 40% of the 150 full texts and formally cali-
brated extractions of eligible articles among reviewers.
We clarified the operationalization of the reporting items
by specifying the wording of extraction instructions before
we completed our extractions for the remaining 60% of the
sample.
2.5.2. Reporting items
First, we evaluated if the study title and abstract allowed
a basic classification of the design of the study and indi-
cated the use of routine data (S1 and R1).
Second, we assessed if sufficient details of the evalu-
ated population, exposures or interventions (or risk fac-
tors, predictors, effect modifiers, and so forth), and
outcomes were reported (S2eS4). Transparent reporting
of these items is crucial for research translation to health
care, and specifically in a medical context, this informa-
tion would allow framing of a focused PICO question on
the medical problem (PICO: Population, Intervention,
Control, Outcome) [19].
Third, we assessed codes and classification algorithms
and other basic requirements for replication of analyses
(R2eR5, S5a, S5b). We assessed if sufficient details were
reported on the population, intervention/exposure, and out-
comes (R2eR4) as prerequisite to facilitate repetition of
the analyses in the same or another data set (for simplicity,
we do not differentiate between replication and reproduc-
tion). RCD studies typically require an exact operationali-
zation of the same items that are used for framing a
focused research question in the previous domain. For
example, when administrative data such as diagnostic codes
are used to define a population with type 2 diabetes, this
would require an exhaustive list of all codes used to define
this disease in the specific study context (e.g., International
Classification of Diseases E11); when electronic medical
records are used to identify these patients, a list of specific
terms indicating the disease would be required (e.g., ‘‘dia-
betes mellitus type 2’’ or ‘‘T2DM’’). We evaluated these
code-related items (i.e., R2eR4) only for studies using
administrative data or electronic health or medical records
because in this context, the retrospective identification of
the population, exposures or intervention, or outcomes usu-
ally requires such codes and/or classification algorithms. In
studies using registry data, codes may be less relevant, for
example, when patients are actively recruited or outcomes
are specifically measured for the purpose of the registry.
We also evaluated whether the description of the analyzed
databases was clear enough to assess the generalizability of
Table 1. Items for evaluation of reporting quality
Item Description
[S1] Is the study’s design indicated with a commonly used term in the title or the abstract?
We accepted any term for study designs (such as ‘‘cohort study’’ or ‘‘caseecontrol study’’) used in typical study classification
schemes [18].
[R1] Is the use of routinely collected data or registry data clearly mentioned in the title or the abstract using common terms?
We evaluated whether information in the title or abstract allows a reader or a database search engine to clearly recognize the use of
routinely collected or registry data.
[S2] Are the selection criteria for the analyzed participants clearly described?
This was deemed adequate when the study participant selection was reported in a way that it would be clear to whom the results
directly apply and for whom they would not be applicable.
[R2] Is the coding/classification of patients clearly described with sufficient details?
We deemed reporting adequate when the description of the coding or classification algorithm was sufficiently clear to allow
replication of the analysis.
[S3] Are all interventions/exposures of interest clearly described?
We deemed an exposure or intervention (or risk factor, predictor, effect modifier, and so forth) sufficiently described when the
provided details would allow the application of the intervention or the measurement of exposure (or risk factor and so forth) in
practice. The reader should know precisely which action (e.g., prescription of a certain dose of a drug) or exposure is being
assessed in the study [19].
[R3] Is the coding/classification of the interventions/exposures clearly described with sufficient details?
We deemed reporting adequate when the description of the coding or classification algorithm was sufficiently clear to allow
replication of the analysis.
[S4] Are all outcomes of interest clearly described?
The outcome description was deemed adequate if it was equivalent to an outcome description in a planned prospective study
designed to specifically investigate the issue (regardless whether such study would be interventional or observational, feasible or
not) and if the detail given was sufficient for others to replicate the study. We did not assess if broad or specific outcomes were
used, but we assessed if the reporting clearly defined the outcome and how it was measured and defined. For example, we deemed
it insufficient when authors reported ‘‘we analyzed effects on hypertension’’ without giving a definition of hypertension (e.g.,
defined by more than one prescription of an antihypertensive drug within 6 months); or when authors say ‘‘we evaluated effects on
mortality’’ without stating whether all-cause or cause-specific mortality has been investigated and without reporting the time-frame
(e.g., in-hospital mortality or 30-day-after discharge mortality).
[R4] Is the coding/classification of the outcomes clearly described with sufficient details?
We deemed reporting adequate when the description of the coding or classification algorithm was sufficiently clear to allow
replication of the analysis. We deemed it unnecessary for replication that all-cause mortality is operationalized with a specific code
because this outcome is typically clear.
[S5] Are the independent variables in analytic models
(1) listed (or are the strategies used to create models reported)?
We deemed reporting adequate when all analyzed variables (e.g., age, body weight, smoking) were listed.
(2) described in sufficient detail (including categorization) to replicate the study?
We deemed reporting adequate when details were provided on how the variables were included in the statistical models (e.g., age and
body weight both as continuous variable and smoking as categorical variable such as ‘‘never smokers,’’ ‘‘previous smokers,’’
‘‘smoking 1 to 10 cigarettes daily,’’ and ‘‘smoking more than 11 cigarettes daily’’).
[R5] Are the characteristics of the analyzed data sets clearly described, including (1) covered time period, (2) location, (3) setting, and
other potentially important factors?
We deemed that reporting was adequate when the covered time period, geographic location, care setting, and other potentially
important factors (e.g., essential details about type of data used; decision on a case-by-case basis) were reported.
[R6] Are the methods of linkage of databases clearly described (if applicable)?
[R7] Are issues of data sharing clearly addressed, i.e., whether the data set is publicly available (or shared on request)?
We accepted any statement regardless of how detailed it was.
[R8] Is the validation of classification algorithms used for patients, interventions/outcomes/exposures described (if applicable)?
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(R5). Then, we evaluated the description of variables and
models in statistical analyses (S5a, S5b), but we only as-
sessed multivariable analyses as they are the most
frequently used statistical method in this research field.
Fourth, we evaluated RCD specifics (R6eR8), that is,
the reporting of methods for linkage of multiple data-
bases (where applicable); any statements about data
sharing issues or the availability of the used data set
for other researchers; and any statements about the vali-
dation of coding or classification algorithms used for
identification of patients, interventions or exposures, oroutcomes were made. We analyzed this item in all
studies using electronic health or medical records
or administrative data for the reasons outlined above
(items R2eR4).2.6. Statistical analysis
Citation metrics of studies with adequate and inadequate
reporting were compared per reporting item using the Man-
neWhitney U test. We used Stata 13.1 (Stata Corp, College
Station, TX, USA) for statistical analysis. P-values are two
tailed.
108 L.G. Hemkens et al. / Journal of Clinical Epidemiology 79 (2016) 104e1113. Results
3.1. Selection and characteristics of studies
Of 150 articles evaluated as full texts, 26 articles were
excluded (21 were no RCD studies and 5 reported no
health-related outcomes). We included 124 eligible articles
for further analysis. Most studies used registry data
(n 5 70; 56.5%) or administrative health data (n 5 40;
32.3%) (Table 2). A single data source was used in 74
studies (59.7%) and two data sources in 24 studies
(19.4%). Epidemiologic questions were addressed in 91
studies (73.4%) and clinical questions in 25 studies
(20.2%). Most studies reported multivariable modelsTable 2. Characteristics of analyzed RCD study sample
Characteristics Studies, n (%)
Studies (n) 124 (100)
Number of routine data sources
Single data source 74 (59.7)
2 data sources 24 (19.4)
3 data sources 9 (7.3)
4 data sources 9 (7.3)
5 or more data sources 8 (6.5)
Type of routine dataa
Administrative data, not health 26 (21.0)
Administrative health data 40 (32.3)
Prescription data 13 (10.5)
Other administrative health data 37 (29.8)
EMR/EHR 19 (15.3)
Registry 70 (56.5)
Disease registry 64 (51.6)
Device registry 7 (5.6)
Other 14 (12.1)
Area of research
Clinical/medical 25 (20.2)
Epidemiology 91 (73.4)
Other or both areas 8 (6.5)
Statistical analyses
Multivariable analysesa 81 (65.3)
Propensity scoresa 5 (4.0)
Other or purely descriptive 43 (34.7)
Type of condition
Cancer 35 (28.2)
Cardiovascular disease 17 (13.7)
Endocrinology 6 (4.8)
Nephrology 3 (2.4)
Neurology/psychiatry 10 (8.1)
Other or healthy participants 53 (42.7)
Citation impact
IF 2012 (median, IQR)
(range), n 5 118
3.12 (2.16; 4.16)
[0.15e25.12]
Citations (median, IQR)
(range), n 5 124
5 (2; 10.5) [0e68]
Endorsement of STROBE 17 (13.7)
Abbreviations: STROBE, STrengthening the Reporting of OBserva-
tional studies in Epidemiology; RCD, routinely collected data; EMR,
electronic medical record; EHR, electronic health record; IF, impact
factor; IQR, interquartile range.
Citations up to February 2015 as of ISI Web of Knowledge (all da-
tabases); STROBE endorsement as of March 2016.
a More than one category may apply.(n 5 81; 65.3%) and five studies (4.0%) used propensity
scores.
3.2. Reporting quality
The study design was not clearly described in the title or
abstract of most studies (inadequate reporting for S1:
62.9%), but many studies were there clearly described as
using RCD (adequate reporting for R1: 71.8%; Table 3).
Many studies clearly reported the evaluated population,
exposures or interventions, or outcomes according to
STROBE (adequate reporting for S2: 74.2%; S3: 77.5%;
S4: 75.7%; Table 3), but only 51 studies (41.1%) reported
all of the three items adequately.
Most studies did not adequately report the coding or
classification algorithm (inadequate reporting for R2:
53.2%; R3: 58.2%; R4: 42.6%; Table 3). In 44 studies,
replication would require coding or classification informa-
tion for all three items because they used administrative
data or electronic medical/health records to describe the
population, exposures or interventions, and outcomes. Only
9 of these 44 studies (20.5%) reported all three items
adequately, whereas 17 (38.6%) reported all items inade-
quately, as would be required to frame a focused research
question.
Across 81 studies using multivariable analyses, 54
studies provided a complete list of used variables (S5a
adequate: 66.7%), but only 34 studies sufficiently reported
basic details required for replication (S5b adequate: 42%).
The analyzed databases were clearly described for most
studies (R5 adequate: 60.5%), but the majority of studies
did not clearly report the methods used for database linkage
(R6 inadequate 68.3%), did not make statements on data
sharing or availability of data sets (R7 inadequate: 96%),
or about the validation of classification algorithms (R8
inadequate: 75.8%).
The agreement between both reviewers across all 14
items was 74.1% (median agreement per item).
3.3. Association with journal IF and citation count
The journal IF was higher for studies that clearly re-
ported details on the statistical analyses (S5a: IF 3.5 vs.
3.2; P 5 0.027. S5b: IF 3.7 vs. 3.2, P 5 0.013), provided
sufficient details on the study outcomes (S4: IF 3.4 vs.
2.6; P 5 0.047), and clearly described the coding and clas-
sification of participants (R2: IF 3.6 vs. 2.5; P 5 0.006)
(Table 4). We found no significant association between
journal IF and other reporting domains or between report-
ing quality and number of citations.4. Discussion
Our systematic analysis of 124 studies reveals a number
of deficiencies in the reporting of research using RCD.
Most studies were insufficiently reported as they have
Table 3. Reporting quality in RCD studies
Reporting item
Reporting adequate
Studies, n Interrater agreement (%)Yes, n (%) Partly, n (%) No, n (%)
STROBE related
[S1] Study design in title or abstract 39 (31.5) 7 (5.6) 78 (62.9) 124 73.1
[S2] Selection criteria of participants 92 (74.2) 18 (14.5) 14 (11.3) 124 77.6
[S3] Details on interventions/exposures 86 (77.5) 13 (11.7) 12 (10.8) 111 69.2
[S4] Details on outcomes 87 (75.7) 19 (16.5) 9 (7.8) 115 78.5
[S5a] Variables used for analyses listeda 54 (66.7) 15 (18.5) 12 (14.8) 81 66.2
[S5b] . described in sufficient detail 34 (42) 10 (12.3) 37 (45.7) 81 50.6
RCD related
[R1] Use of RCD/registry data in title/abstract 89 (71.8) 1 (0.8) 34 (27.4) 124 75.2
[R2] Coding of participants 26 (41.9) 3 (4.8) 33 (53.2) 62 74.1
[R3] Coding of interventions/exposures 20 (36.4) 3 (5.5) 32 (58.2) 55 57.7
[R4] Coding of outcomes 29 (53.7) 2 (3.7) 23 (42.6) 54 74.0
[R5] Characteristics of data source 75 (60.5) 32 (25.8) 17 (13.7) 124 73.0
[R6] Methods of data linkage 12 (29.3) 1 (2.4) 28 (68.3) 41 92.3
[R7] Data availability/sharing 3 (2.4) 2 (1.6) 119 (96) 124 87.8
[R8] Validation of classification algorithms 13 (19.7) 3 (4.6) 50 (75.8) 66 82.3
Abbreviations: STROBE, STrengthening the Reporting of OBservational studies in Epidemiology; RCD, routinely collected data.
Not all items were applicable for all studies, please see Section 2 for details.
a Or the strategies used to create models reported.
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particular methodology for using RCD (e.g., database link-
age or used codes and their accuracy and validity). This un-
derlines the necessity to establish specific reporting
guidelines for RCD studies, such as the REporting of
studies Conducted using Observational Routinely collected
health Data (RECORD) statement [13] and the importance
of adequate implementation by journals, peer reviewers,
and funding agencies.
We also found substantial reporting deficits that concern
observational studies in general. They relate to areas of re-
porting that are already addressed by established reporting
guidelines (STROBE). We found that less than half of the
evaluated studies provided complete information to frame
a focused research question, that is, it was frequently
impossible to know which exposure or intervention was
associated with which outcome and in which population.
The descriptions of statistical analyses in most studies
lacked minimal prerequisites for replication and assessment
of scientific validity: about one-third of studies that used
multivariable models did not provide a complete list of
the variables used for modeling; basic details on how the
variables were used were provided in less than half of the
studies.
Journal IF was associated with quality of reporting in
few areas, underlining that insufficient reporting is a ubiq-
uitous problem and affects both low- and high-impact jour-
nals. We found no relationship between reporting and
citation counts, in contrast to a recent study that evaluated
reporting of systematic reviews and meta-analyses in one
medical field (radiology) [20]. Since only few articles were
published in journals endorsing STROBE, we did not eval-
uate the association of STROBE endorsement and reporting
quality. A recent Lancet series corroborated the fact that
poor reporting of key information is endemic in variousareas of health research and affects any study type,
including randomized trials, observational studies, labora-
tory research, and animal studies [4]. Our analysis is
consistent with previous work on other forms of observa-
tional studies [6e11]. Even years after publication of the
STROBE guideline, reporting of observational research is
still deficient.
Our work has some limitations. First, we explored only a
small number of reporting items that reflect information
which we deemed essential for RCD studies and there are
further and more expanded items in the RECORD guideline
[13]. Other relevant issues remain unaddressed in our anal-
ysis. For example, when we evaluated the replicability of
statistical analyses, we addressed only obvious aspects of
reporting of multivariable analyses. According to the Inter-
national Committee of Medical Journal Editors, statistical
methods should be described ‘‘with enough detail to enable
a knowledgeable reader with access to the original data to
judge its appropriateness for the study and to verify the re-
ported results’’ [21]. We did not evaluate other details that a
reader would likely require for replication, such as the
availability of statistical code, but we found that almost
all articles lacked a statement about access to the original
data.
Second, our sample drawn from publications of the year
2012 in English language from journals indexed in MED-
LINE is only a fraction of the entire literature. However,
it is unlikely that reporting quality has substantially
changed in the meantime and it remains speculative if our
findings also apply to studies reported in other journals or
languages.
Third, we searched the literature using terms that might
have enriched the sample with studies mentioning RCD
terms in title or abstract. Thus, the finding that titles or ab-
stracts of RCD studies often indicate the use of routine data
Table 4. Association of reporting quality with journal impact factor and citation count
Reporting item
Reporting
adequate Impact factor 2012 P-value Citations per article P-value Studies (n)
STROBE related
[S1] Study design in title or abstract Yes 3.4 (1.9; 4.5) 0.87 5 (2; 11) 0.427 39
No 3 (2.3; 3.9) 4 (2; 9) 78
[S2] Selection criteria of participants Yes 3.1 (2.1; 4.5) 0.737 5 (2; 9.5) 0.973 92
No 3.2 (2.8; 3.9) 7 (4; 15) 14
[S3] Details on interventions/exposures Yes 3.3 (2.2; 4.3) 0.733 5 (2; 11) 0.268 86
No 3.1 (2.5; 3.2) 3 (1; 9.5) 12
[S4] Details on outcomes Yes 3.4 (2.2; 4.5) 0.047 5 (2; 11) 0.057 87
No 2.6 (1.9; 3.4) 4 (1; 10) 9
[S5a] Variables used for analyses listeda Yes 3.5 (2.2; 4.9) 0.027 5 (2; 12) 0.223 54
No 3.2 (2.6; 4.2) 4.5 (2; 13) 12
[S5b] . described in sufficient detail Yes 3.7 (2.4; 5.1) 0.013 6 (3; 11) 0.277 34
No 3.2 (2.2; 4.2) 6 (2; 13) 37
RCD related
[R1] Use of RCD/registry data in title/abstract Yes 3.3 (2.1; 4.4) 0.554 5 (2; 10) 0.876 89
No 2.9 (2.3; 3.4) 3.5 (2; 9) 34
[R2] Coding of participants Yes 3.6 (2.8; 5.6) 0.006 5.5 (3; 11) 0.427 26
No 2.5 (1.9; 3.7) 2 (1; 7) 33
[R3] Coding of interventions/exposures Yes 3.5 (2.3; 4.7) 0.081 5.5 (2.5; 15) 0.259 20
No 2.3 (1.9; 3.7) 3 (1; 7) 32
[R4] Coding of outcomes Yes 3.6 (2.2; 5.2) 0.11 5 (3; 7) 0.882 29
No 2.6 (2.2; 3.3) 3 (1; 11) 23
[R5] Characteristics of data source Yes 3.1 (2.2; 4.3) 0.538 4 (2; 11) 0.471 75
No 2.8 (2.2; 3.7) 6 (1; 11) 17
[R6] Methods of data linkage Yes 2.8 (2.1; 4.8) 0.963 4.5 (3; 10) 12
No 3.3 (2.1; 4.5) 5 (2; 10) 0.932 28
[R7] Data availability/sharing Yes 17.2 (2.4; 18) 0.108 14 (4; 19) 0.135 3
No 3.1 (2.2; 4.1) 4 (2; 10) 119
[R8] Validation of classification algorithms Yes 3.5 (2.5; 5.4) 0.206 6 (4; 8) 0.466 13
No 2.7 (2.2; 4.2) 3.5 (1; 8) 50
Abbreviations: STROBE, STrengthening the Reporting of OBservational studies in Epidemiology; RCD, routinely collected data.
Impact factors for 2012 were not available for publishing journals of six studies; citations up to February 2015 as of ISI Web of Knowledge (all
databases); impact factors and citation counts are medians with interquartile ranges.
a Or the strategies used to create models reported.
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reviewed search strategy that was deemed accurate and
complete for the identification of observational RCD
studies. Therefore, we believe the sample of included
studies allows generalizing the findings to the larger RCD
literature.
Fourth, we assessed the reporting by two independent re-
viewers using their best subjective judgment. However, all
involved researchers had training in research reporting,
used standardized and piloted electronic extraction forms
with detailed instructions, and we systematically calibrated
our extractions during the process resulting in an overall in-
terreviewer agreement of 74.1% across all items. The expe-
rience from the consensus process ultimately informed the
discussion and item operationalization during the
RECORD guideline development.
Finally, modern database analyses may frequently use
study designs that do not clearly fit into traditional
study design classifications such as ‘‘cohort study’’ or
‘‘caseecontrol study.’’ Authors of such research may find
the STROBE recommendation to ‘‘indicate the study’s
design with a commonly used term’’ as inappropriate. Thisissue should be considered in future versions of the report-
ing guidelines. Our finding with respect to reporting of the
study design should not be overrated and cautiously
interpreted.
Our results suggest that poor reporting of key study in-
formation is prominent in RCD research and may limit its
further use, for example, by limiting the assessment of its
scientific validity or hindering its replication. The incom-
plete or imprecise description of research questions in most
studies may waste research resources, for example, by un-
necessary replication efforts or misguided funding deci-
sions in their research fields [4]. Generally, reporting
deficits may lead to inefficient, misguided, or haphazard
translation of research findings to public health actions or
medical care.
This study provides a benchmark for the reporting qual-
ity of RCD studies. Preliminary findings of this project
were presented to the working committee of RECORD
and informed the guideline development. Areas discovered
by this study to be poorly reported have been emphasized in
the RECORD guideline [13]. Authors, peer reviewers, and
editors need training to apply both novel and established
111L.G. Hemkens et al. / Journal of Clinical Epidemiology 79 (2016) 104e111reporting guidelines to ensure better and more complete
research reporting. We believe that adoption of such guide-
lines and education on their use is particularly urgent to
improve the utility of research using RCD.Acknowledgments
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